Dr. Reddy's Laboratories Limited
RDY
$13.47
$0.060.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.84% | -0.71% | 16.99% | 1.01% | -16.28% |
| Total Depreciation and Amortization | 21.92% | 21.91% | 17.67% | 23.35% | 3.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -316.88% | -3.27% | 135.29% | -163.34% | 117.26% |
| Change in Net Operating Assets | 68.50% | 39.24% | 120.28% | 19.80% | -394.49% |
| Cash from Operations | 60.39% | 67.85% | 83.18% | 37.72% | -48.70% |
| Capital Expenditure | 33.50% | -30.88% | -40.17% | -84.86% | -101.91% |
| Sale of Property, Plant, and Equipment | -49.98% | -84.40% | -118.09% | -79.12% | -55.50% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -110.71% | 21.43% | 38.11% | 112.46% | 3,111.61% |
| Cash from Investing | 51.99% | 7.60% | -12.42% | 66.76% | -316.74% |
| Total Debt Issued | -84.67% | -99.34% | -1,404.80% | -64.30% | -- |
| Total Debt Repaid | 45.06% | -8.67% | 4.89% | -143.90% | 25.89% |
| Issuance of Common Stock | -33.33% | 931.58% | -64.52% | 177.78% | -79.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.10% | -- | -- | -- | 1.09% |
| Other Financing Activities | -118.34% | -53.63% | -25.71% | -76.38% | 1,356.47% |
| Cash from Financing | -131.62% | -112.29% | -1,226.54% | -88.99% | 326.56% |
| Foreign Exchange rate Adjustments | 913.40% | 914.92% | 446.83% | -103.06% | 65.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -86.42% | -148.32% | 449.90% | 128.69% | -0.28% |